LifeVantage Corporation LFVN
At closeNov 4, 2026, 4:00 PM EST
After hours · Nov 4, 4:00 PM ET
Day range unavailable
- YTD
- -3.08%
- 1 year
- -14.71%
- Market cap
- 75.16M
- Revenue (ttm)
- 196.01M
- Profit margin
- 2.11%
- EPS (ttm)
- 0.40
- Shares out
- 12.53M
- P/E ratio
- 14.93
- Forward P/E
- 19.70
- Dividend
- 0.16 (3.41%)
- Ex-dividend date
- Dec 1, 2024
- YTD return
- -3.08%
- 1-year return
- -14.71%
- Avg volume
- 39.67K
- Previous close
- 5.97
- 52-week range
- 3.90 – 11.71
- Beta
- 0.86
- Analysts
- Strong Buy
- Price target
- 26.00 (+335.5%)
2Y -8.51 (-58.93%)
Key statistics
- Enterprise value
- 216.20M
- PEG ratio
- 0.00
- Price / sales
- 1.04
- Price / book
- 7.37
- Dividend yield
- 0.94%
- Payout ratio
- 46.88%
- Revenue growth
- -8.10%
- Free cash flow
- 6.92M
- Total cash
- 14.60M
- Total debt
- 13.36M
- Return on equity
- 14.51%
- Short % of float
- 1.97%
- 50-day average
- 13.94
- 200-day average
- 9.25
Analyst view
Consensus: strong buy
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.14.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 29, 2024 | Sep 1, 2024 | 0.00 | 0.15 | — | — |
| Aug 28, 2024 | Jun 1, 2024 | 0.00 | 0.14 | — | — |
| May 2, 2024 | Mar 1, 2024 | 0.00 | 0.21 | — | — |
| Jan 30, 2024 | Dec 1, 2023 | 0.00 | 0.10 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | 0.13 | — | — |
| Aug 28, 2023 | Jun 1, 2023 | 0.00 | 0.17 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 19, 2024 | Lake Street | init | — | Buy |
| Feb 12, 2014 | Imperial Capital | init | — | In-Line |
About LifeVantage Corporation
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement designed to strengthen immune health; LifeVantage Rise AM & Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3, vitamin K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company is headquartered in Lehi, Utah.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Country
- United States
- Website
- lifevantage.com
News
New LifeVantage Research Explores How Protandim® Nrf2 Supports Cellular Defense Against Five Modern Environmental Toxins* 
Lake Street Maintains Hold on Lifevantage, Raises Price Target to $6 
12 Consumer Staples Stocks Moving In Thursday's After-Market Session 
Lifevantage Q4 2026 Earnings Call Transcript 
LifeVantage Plans To Not Issue FY27 Outlook Due To Recent CEO Transition 
Lifevantage Q4 Adj. EPS $0.11 Misses $0.13 Estimate, Sales $42.377M Miss $45.949M Estimate - Lifevantage Names Terrence Moorehead As CEO
- 12 Consumer Staples Stocks Moving In Monday's Pre-Market Session
Why Did LifeVantage (LFVN) Stock Jump 27% After Hours? 
Earnings Scheduled For May 6, 2026
Your note
Sign in to keep a note on LFVN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANBALAGAN RAJENDRAN | Director | Stock Award(Grant) | Nov 6, 2024 | 10,468 |
| AURE CARL | Chief Financial Officer | Conversion of Exercise of derivative security | Sep 30, 2024 | 138,746 |
| BEINDORFF MICHAEL A | Director | Stock Award(Grant) | Nov 6, 2024 | 130,072 |
| CUNNINGHAM KRISTEN | Officer | Conversion of Exercise of derivative security | Sep 30, 2024 | 107,581 |
| GREER RAYMOND B | Director | Stock Award(Grant) | Nov 6, 2024 | 107,288 |
| JUDD DAYTON R | Director | Stock Award(Grant) | Nov 6, 2024 | 782,956 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 6.61% | 828,118 | 13.54M | Sep 29, 2024 |
| Vanguard Group Inc | 3.97% | 497,778 | 8.14M | Sep 29, 2024 |
| Capital Management Corporation | 3.35% | 419,930 | 6.87M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 2.37% | 296,371 | 4.85M | Sep 29, 2024 |
| Envestnet Asset Management | 1.78% | 222,873 | 3.64M | Sep 29, 2024 |
| Blackrock Inc. | 1.60% | 200,156 | 3.27M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.31% | 289,613 | 4.74M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.56% | 195,113 | 3.19M | Sep 29, 2024 |
| EA Series Trust-EA Bridgeway Omni Small-Cap Value ETF | 0.63% | 78,859 | 1.29M | Sep 29, 2024 |
| DFA U.S. Small Cap Series | 0.58% | 72,727 | 1.19M | Jul 30, 2024 |
| Avantis U.S. Small Cap Value ETF | 0.50% | 62,076 | 1.01M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.48% | 59,513 | 973.04K | Oct 30, 2024 |